image
Enanta Pharmaceuticals, Inc. ENTA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
BALANCE SHEET
377 M ASSETS
-18.52%
Growth Rates
1Year -18.52%
3Years -4.96%
5Years -5.12%
7Years 2.06%
10Years 9.26%
248 M LIABILITIES
0.94%
Growth Rates
1Year 0.94%
3Years 84.66%
5Years 55.41%
7Years 38.81%
10Years 43.36%
129 M EQUITY
-40.57%
Growth Rates
1Year -40.57%
3Years -31.42%
5Years -22.56%
7Years -11.45%
10Years -1.42%
BALANCE SHEET DECOMPOSITION
Balance Sheet Enanta Pharmaceuticals, Inc.
image
Current Assets 300 M
Cash & Short-Term Investments 248 M
Receivables 6.65 M
Other Current Assets 45 M
Non-Current Assets 76.8 M
Long-Term Investments 0
PP&E 73.3 M
Other Non-Current Assets 3.45 M
Current Liabilities 57.5 M
Accounts Payable 8 M
Short-Term Debt 3.05 M
Other Current Liabilities 46.5 M
Non-Current Liabilities 190 M
Long-Term Debt 53.9 M
Other Non-Current Liabilities 136 M

Balance Sheet

Millions
Sep-2024 Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Sep-2018 Sep-2017 Sep-2016 Sep-2015 Sep-2014 Sep-2013 Sep-2012 Sep-2011
ASSETS
Cash & Cash Equivalents 37.2 85.4 44.0 57.2 87.1 51.2 63.9 65.7 16.6 21.7 30.7 8.9 10.5 6.8
Short Term Investments 211.0 284.5 205.2 186.8 299.5 284.0 244.8 158.0 193.5 123.5 60.1 92.6 33.3 16.5
Receivables 6.6 39.6 49.0 60.8 23.5 51.3 67.2 10.6 12.8 15.7 4.5 1.6 2.9 0.3
Inventory 0 0 0 (37.3) 0 0 0 0 0 1 1 0 1 0
Other Current Assets 45.0 13.3 13.4 14.2 40.4 30.6 8.9 7.1 18.5 18.0 14.3 3.3 0.6 1.5
Total Current Assets 299.9 422.8 311.7 319.0 436.8 401.8 380.4 237.8 232.2 170.6 108.0 104.7 47.3 25.1
PP&E 73.3 34.7 29.7 10.7 15.6 10.9 8.4 8.0 8.0 5.9 1.8 1.1 0.6 0.5
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 29.3 108.4 32.6 65.0 16.4 70.0 32.1 64.2 41.0 10.7 1.7 0
Other Long Term Assets 3.5 4.8 4.7 0.7 0.7 0.7 0.7 0.6 0.6 0.6 0.4 0.4 2.6 0.5
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 376.7 462.3 375.4 438.8 486.1 489.8 414.2 326.6 281.3 246.0 155.4 117.0 52.2 26.1
LIABILITIES
Accounts Payable 8.0 4.1 6.0 9.5 5.7 6.7 4.7 3.7 3.4 1.5 1.9 1.5 1.9 0.6
Short Term Debt 3.0 5.3 5.8 8.4 8.5 0 0 79 K 73 K 69 K 0 0 0 0
Other Current Liabilities 46.5 53.4 18.0 18.2 9.9 15.9 9.9 7.9 4.4 3.9 2.9 3.0 3.9 1.6
Total Current Liabilities 57.5 62.8 29.8 36.2 24.2 22.6 16.0 21.0 7.9 6.7 4.7 4.5 5.7 2.1
Long Term Debt 53.9 21.2 22.4 1.1 5.3 0.2 0.3 0.4 0.5 0.5 0 0 0 0
Deferred Tax Income 0 0 5.2 2.1 0.8 1.7 1.8 1.2 0.7 0.4 0 0 0 0
Other Liabilities 136.4 161.5 1.9 2.1 1.1 4.5 4.2 3.6 3.0 2.6 2.0 2.0 2.5 155.9
Total Liabilities 247.8 245.5 54.1 39.4 30.6 27.3 20.5 25.0 11.3 9.9 6.8 6.5 8.2 158.1
EQUITY
Common Stock 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 13 K 53 K
Retained Earnings (323.0) (207.0) (73.2) 48.6 127.6 163.7 117.4 45.4 27.6 6.0 (73.0) (107.5) (115.4) (132.0)
Other Accumulative Comprehensive Income/Loss 0.3 (1.2) (3.7) (0.4) 0.8 0.1 (0.4) (0.1) 19 K 33 K 100 K 2 K 10 K 1 K
Total Equity 128.8 216.7 321.3 399.4 455.6 462.5 393.7 301.7 269.9 236.2 148.7 110.5 43.9 (132.0)
Total Liabilities and Equity 376.7 462.3 375.4 438.8 486.1 489.8 414.2 326.6 281.3 246.0 155.4 117.0 52.2 26.1
SHARES OUTSTANDING
Common Shares Outstanding 21.2 21.0 20.6 20.2 19.9 19.6 20.6 19.1 18.9 18.7 18.4 9.8 1.2 1.2 12.7